Papers

Peer-reviewed International journal
Nov, 2017

Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations

PLOS ONE
  • Nori Yoshioka
  • Matsuo Deguchi
  • Hideharu Hagiya
  • Masanori Kagita
  • Hiroko Tsukamoto
  • Miyuki Takao
  • Hisao Yoshida
  • Norihisa Yamamoto
  • Yukihiro Akeda
  • Yoshiko Nabetani
  • Ikuhiro Maeda
  • Yoh Hidaka
  • Kazunori Tomono
  • Display all

Volume
12
Number
11
First page
e0187661
Last page
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1371/journal.pone.0187661
Publisher
PUBLIC LIBRARY SCIENCE

Background
Health care workers (HCWs) are frequently exposed to hepatitis B virus (HBV) infection. The efficacy and safety of immunization with the hepatitis B (HB) vaccine are well recognized, but the durability of immunity and need for booster doses in those with secondary vaccine response failure remains controversial.
Methods
This was a retrospective cohort study performed at Osaka University Hospital, Japan. We examined antibodies against HB surface antigen (anti-HBs) titers annually after immunization for previously non-immunized HCWs. Primary responders were categorized by their sero-positive durations as short responders (those whose anti-HBs titers declined to negative range within 3 years), and long responders (those who retained positive anti-HBs levels for 3 years and more). We re-immunized short responders with either single or 3-dose boosters, the long responders with a single booster when their titers dropped below protective levels, and examined their sero-protection rates over time thereafter.
Results
From 2001 to 2012, data of 264 HCWs with a median age of 25.3 were collected. The rate of anti-HBs positivity after primary vaccination were 93.0% after three doses (n = 229), 54.5% after two doses (n = 11), and 4.2% after a single dose (n = 24). Of 213 primary responders, the anti-HBs levels of 95 participants (44.6%) fell below the protective levels, including 46 short responders and 49 long responders. HCWs with higher initial anti-HBs titers after primary vaccination had significantly longer durations of sero-positivity. For short responders, 3-dose booster vaccination induced a longer duration of anti-HBs positivity compared to a single-dose booster, whereas for long responders, a single-dose booster alone could induce prolonged anti-HBs positivity.
Conclusion
Our preliminary data suggested that it may be useful to differentiate HB vaccine responders based on their primary response durations to maintain protective levels of anti-HBs efficiently. A randomized, prospective, large-scale study is warranted to support our findings.

Link information
DOI
https://doi.org/10.1371/journal.pone.0187661
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29121107
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679562
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000414769900061&DestApp=WOS_CPL
ID information
  • DOI : 10.1371/journal.pone.0187661
  • ISSN : 1932-6203
  • Pubmed ID : 29121107
  • Pubmed Central ID : PMC5679562
  • Web of Science ID : WOS:000414769900061

Export
BibTeX RIS